Literature DB >> 26545171

Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Adelheid Woehrer1, Johannes A Hainfellner1.   

Abstract

Several morphology- and polymerase chain reaction (PCR)-based methods for chromosome 1p 19q deletion status assessment are available. Important prerequisites for all molecular techniques concern tissue quality and selection of regions of interest. The most common methods for diagnostic 1p 19q assessment are fluorescence in situ hybridization and PCR-based microsatellite analysis. While the latter requires the use of autologous blood samples, more advanced techniques such as array comparative genomic hybridization, multiplex ligation-dependent probe amplification or real-time PCR are independent from autologous DNA samples. However, due to high technical demand and experience required their applicability as diagnostic tests remains to be shown. On the other hand, chromogenic in situ hybridization evolves as attractive alternative to FISH. Herein, the available test methods are reviewed and outlined, their advantages and drawbacks being discussed in detail.

Keywords:  1p 19q deletion; analytical performance; clinical performance; oligodendroglial tumors

Mesh:

Year:  2015        PMID: 26545171      PMCID: PMC6082333          DOI: 10.2217/cns.15.28

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  66 in total

1.  Comparative genomic hybridization pattern of non-anaplastic and anaplastic oligodendrogliomas--a meta-analysis.

Authors:  Ronald Koschny; Heidrun Holland; Thomas Koschny; Hans-Ekkehart Vitzthum
Journal:  Pathol Res Pract       Date:  2005-12-13       Impact factor: 3.250

2.  Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis.

Authors:  Shuko Harada; Lindsay B Henderson; James R Eshleman; Christopher D Gocke; Peter Burger; Constance A Griffin; Denise A S Batista
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

3.  Gliosarcoma arising from an oligodendroglioma (oligosarcoma).

Authors:  Annie Hiniker; Jill M Hagenkord; Martin P Powers; Manish K Aghi; Michael D Prados; Arie Perry
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368

4.  Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.

Authors:  Esther H Lips; Jan Willem F Dierssen; Ronald van Eijk; Jan Oosting; Paul H C Eilers; Rob A E M Tollenaar; Eelco J de Graaf; Ruben van't Slot; Cisca Wijmenga; Hans Morreau; Tom van Wezel
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

5.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Authors:  S H Bigner; M R Matthews; B K Rasheed; R N Wiltshire; H S Friedman; A H Friedman; T T Stenzel; D M Dawes; R E McLendon; D D Bigner
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.

Authors:  K Lindblad-Toh; D M Tanenbaum; M J Daly; E Winchester; W O Lui; A Villapakkam; S E Stanton; C Larsson; T J Hudson; B E Johnson; E S Lander; M Meyerson
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

7.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

8.  Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.

Authors:  Carmen Franco-Hernández; Victor Martínez-Glez; Jose M de Campos; Alberto Isla; Jesús Vaquero; Manuel Gutiérrez; Cacilda Casartelli; Juan A Rey
Journal:  Cancer Genet Cytogenet       Date:  2009-04-15

9.  New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.

Authors:  Thierry Gorlia; Jean-Yves Delattre; Alba A Brandes; Johan M Kros; Martin J B Taphoorn; Mathilde C M Kouwenhoven; H J J A Bernsen; Marc Frénay; Cees C Tijssen; Denis Lacombe; Martin J van den Bent
Journal:  Eur J Cancer       Date:  2013-07-26       Impact factor: 9.162

10.  Detection of 1p19q deletion by real-time comparative quantitative PCR.

Authors:  Abhishek Chaturbedi; Liping Yu; Mark E Linskey; Yi-Hong Zhou
Journal:  Biomark Insights       Date:  2012-02-01
View more
  14 in total

1.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

2.  Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.

Authors:  Yuqi Han; Zhen Xie; Yali Zang; Shuaitong Zhang; Dongsheng Gu; Mu Zhou; Olivier Gevaert; Jingwei Wei; Chao Li; Hongyan Chen; Jiang Du; Zhenyu Liu; Di Dong; Jie Tian; Dabiao Zhou
Journal:  J Neurooncol       Date:  2018-08-10       Impact factor: 4.130

3.  Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.

Authors:  Burak Kocak; Emine Sebnem Durmaz; Ece Ates; Ipek Sel; Saime Turgut Gunes; Ozlem Korkmaz Kaya; Amalya Zeynalova; Ozgur Kilickesmez
Journal:  Eur Radiol       Date:  2019-11-05       Impact factor: 5.315

Review 4.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

5.  A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.

Authors:  Chandan Ganesh Bangalore Yogananda; Bhavya R Shah; Frank F Yu; Marco C Pinho; Sahil S Nalawade; Gowtham K Murugesan; Benjamin C Wagner; Bruce Mickey; Toral R Patel; Baowei Fei; Ananth J Madhuranthakam; Joseph A Maldjian
Journal:  Neurooncol Adv       Date:  2020-07-17

Review 6.  Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections.

Authors:  Maisa Yoshimoto; Olga Ludkovski; Jennifer Good; Ciro Pereira; Robert J Gooding; Jean McGowan-Jordan; Alexander Boag; Andrew Evans; Ming-Sound Tsao; Paulo Nuin; Jeremy A Squire
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

7.  Correlation of immune phenotype with IDH mutation in diffuse glioma.

Authors:  Anna Sophie Berghoff; Barbara Kiesel; Georg Widhalm; Dorothee Wilhelm; Orsolya Rajky; Sebastian Kurscheid; Philip Kresl; Adelheid Wöhrer; Christine Marosi; Monika E Hegi; Matthias Preusser
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 13.029

8.  Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach.

Authors:  Michał Bieńkowski; Adelheid Wöhrer; Patrizia Moser; Melitta Kitzwögerer; Gerda Ricken; Thomas Ströbel; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2018 Jul/Aug       Impact factor: 1.136

9.  The impact of adjuvant radiotherapy on molecular prognostic markers in gliomas.

Authors:  Maciej Harat; Maciej Blok; Aleksandra Harat; Krystyna Soszyńska
Journal:  Onco Targets Ther       Date:  2019-03-26       Impact factor: 4.147

Review 10.  Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.

Authors:  Sebastian Brandner; Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Luke Vale; Julian P T Higgins; Kathreena M Kurian
Journal:  Neuropathol Appl Neurobiol       Date:  2022-03-03       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.